Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Substance Abuse Therapeutics Market Growth (Status and Outlook) 2022-2028

  • LP 4801209
  • 88 Pages
  • January 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Substance Abuse Therapeutics will have significant change from previous year. According to our (LP Information) latest study, the global Substance Abuse Therapeutics market size is USD million in 2022 from USD 17450 million in 2021, with a change of % between 2021 and 2022. The global Substance Abuse Therapeutics market size will reach USD 27350 million in 2028, growing at a CAGR of 6.6% over the analysis period.

The United States Substance Abuse Therapeutics market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Substance Abuse Therapeutics market, reaching US$ million by the year 2028. As for the Europe Substance Abuse Therapeutics landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Substance Abuse Therapeutics players cover Indivior, Pfizer, Alkermes, and Novartis, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Substance Abuse Therapeutics market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.

Opioid Addiction

Tobacco/Nicotine Addiction

Alcohol Dependence

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.

Hospital & Clinics

Residential (non-hospital)

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.

Indivior

Pfizer

Alkermes

Novartis

Mylan

Cipla

Glenmark

Dr. Reddy's Laboratories

Teva Pharmaceutical

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Substance Abuse Therapeutics Market Size 2017-2028

2.1.2 Substance Abuse Therapeutics Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 Substance Abuse Therapeutics Segment by Type

2.2.1 Opioid Addiction

2.2.2 Tobacco/Nicotine Addiction

2.2.3 Alcohol Dependence

2.3 Substance Abuse Therapeutics Market Size by Type

2.3.1 Substance Abuse Therapeutics Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global Substance Abuse Therapeutics Market Size Market Share by Type (2017-2022)

2.4 Substance Abuse Therapeutics Segment by Application

2.4.1 Hospital & Clinics

2.4.2 Residential (non-hospital)

2.5 Substance Abuse Therapeutics Market Size by Application

2.5.1 Substance Abuse Therapeutics Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global Substance Abuse Therapeutics Market Size Market Share by Application (2017-2022)

3 Substance Abuse Therapeutics Market Size by Player

3.1 Substance Abuse Therapeutics Market Size Market Share by Players

3.1.1 Global Substance Abuse Therapeutics Revenue by Players (2020-2022)

3.1.2 Global Substance Abuse Therapeutics Revenue Market Share by Players (2020-2022)

3.2 Global Substance Abuse Therapeutics Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Substance Abuse Therapeutics by Regions

4.1 Substance Abuse Therapeutics Market Size by Regions (2017-2022)

4.2 Americas Substance Abuse Therapeutics Market Size Growth (2017-2022)

4.3 APAC Substance Abuse Therapeutics Market Size Growth (2017-2022)

4.4 Europe Substance Abuse Therapeutics Market Size Growth (2017-2022)

4.5 Middle East & Africa Substance Abuse Therapeutics Market Size Growth (2017-2022)

5 Americas

5.1 Americas Substance Abuse Therapeutics Market Size by Country (2017-2022)

5.2 Americas Substance Abuse Therapeutics Market Size by Type (2017-2022)

5.3 Americas Substance Abuse Therapeutics Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Substance Abuse Therapeutics Market Size by Region (2017-2022)

6.2 APAC Substance Abuse Therapeutics Market Size by Type (2017-2022)

6.3 APAC Substance Abuse Therapeutics Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Substance Abuse Therapeutics by Country (2017-2022)

7.2 Europe Substance Abuse Therapeutics Market Size by Type (2017-2022)

7.3 Europe Substance Abuse Therapeutics Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Substance Abuse Therapeutics by Region (2017-2022)

8.2 Middle East & Africa Substance Abuse Therapeutics Market Size by Type (2017-2022)

8.3 Middle East & Africa Substance Abuse Therapeutics Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global Substance Abuse Therapeutics Market Forecast

10.1 Global Substance Abuse Therapeutics Forecast by Regions (2023-2028)

10.1.1 Global Substance Abuse Therapeutics Forecast by Regions (2023-2028)

10.1.2 Americas Substance Abuse Therapeutics Forecast

10.1.3 APAC Substance Abuse Therapeutics Forecast

10.1.4 Europe Substance Abuse Therapeutics Forecast

10.1.5 Middle East & Africa Substance Abuse Therapeutics Forecast

10.2 Americas Substance Abuse Therapeutics Forecast by Country (2023-2028)

10.2.1 United States Substance Abuse Therapeutics Market Forecast

10.2.2 Canada Substance Abuse Therapeutics Market Forecast

10.2.3 Mexico Substance Abuse Therapeutics Market Forecast

10.2.4 Brazil Substance Abuse Therapeutics Market Forecast

10.3 APAC Substance Abuse Therapeutics Forecast by Region (2023-2028)

10.3.1 China Substance Abuse Therapeutics Market Forecast

10.3.2 Japan Substance Abuse Therapeutics Market Forecast

10.3.3 Korea Substance Abuse Therapeutics Market Forecast

10.3.4 Southeast Asia Substance Abuse Therapeutics Market Forecast

10.3.5 India Substance Abuse Therapeutics Market Forecast

10.3.6 Australia Substance Abuse Therapeutics Market Forecast

10.4 Europe Substance Abuse Therapeutics Forecast by Country (2023-2028)

10.4.1 Germany Substance Abuse Therapeutics Market Forecast

10.4.2 France Substance Abuse Therapeutics Market Forecast

10.4.3 UK Substance Abuse Therapeutics Market Forecast

10.4.4 Italy Substance Abuse Therapeutics Market Forecast

10.4.5 Russia Substance Abuse Therapeutics Market Forecast

10.5 Middle East & Africa Substance Abuse Therapeutics Forecast by Region (2023-2028)

10.5.1 Egypt Substance Abuse Therapeutics Market Forecast

10.5.2 South Africa Substance Abuse Therapeutics Market Forecast

10.5.3 Israel Substance Abuse Therapeutics Market Forecast

10.5.4 Turkey Substance Abuse Therapeutics Market Forecast

10.5.5 GCC Countries Substance Abuse Therapeutics Market Forecast

10.6 Global Substance Abuse Therapeutics Forecast by Type (2023-2028)

10.7 Global Substance Abuse Therapeutics Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 Indivior

11.1.1 Indivior Company Information

11.1.2 Indivior Substance Abuse Therapeutics Product Offered

11.1.3 Indivior Substance Abuse Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 Indivior Main Business Overview

11.1.5 Indivior Latest Developments

11.2 Pfizer

11.2.1 Pfizer Company Information

11.2.2 Pfizer Substance Abuse Therapeutics Product Offered

11.2.3 Pfizer Substance Abuse Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 Pfizer Main Business Overview

11.2.5 Pfizer Latest Developments

11.3 Alkermes

11.3.1 Alkermes Company Information

11.3.2 Alkermes Substance Abuse Therapeutics Product Offered

11.3.3 Alkermes Substance Abuse Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 Alkermes Main Business Overview

11.3.5 Alkermes Latest Developments

11.4 Novartis

11.4.1 Novartis Company Information

11.4.2 Novartis Substance Abuse Therapeutics Product Offered

11.4.3 Novartis Substance Abuse Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 Novartis Main Business Overview

11.4.5 Novartis Latest Developments

11.5 Mylan

11.5.1 Mylan Company Information

11.5.2 Mylan Substance Abuse Therapeutics Product Offered

11.5.3 Mylan Substance Abuse Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 Mylan Main Business Overview

11.5.5 Mylan Latest Developments

11.6 Cipla

11.6.1 Cipla Company Information

11.6.2 Cipla Substance Abuse Therapeutics Product Offered

11.6.3 Cipla Substance Abuse Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 Cipla Main Business Overview

11.6.5 Cipla Latest Developments

11.7 Glenmark

11.7.1 Glenmark Company Information

11.7.2 Glenmark Substance Abuse Therapeutics Product Offered

11.7.3 Glenmark Substance Abuse Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.7.4 Glenmark Main Business Overview

11.7.5 Glenmark Latest Developments

11.8 Dr. Reddy's Laboratories

11.8.1 Dr. Reddy's Laboratories Company Information

11.8.2 Dr. Reddy's Laboratories Substance Abuse Therapeutics Product Offered

11.8.3 Dr. Reddy's Laboratories Substance Abuse Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.8.4 Dr. Reddy's Laboratories Main Business Overview

11.8.5 Dr. Reddy's Laboratories Latest Developments

11.9 Teva Pharmaceutical

11.9.1 Teva Pharmaceutical Company Information

11.9.2 Teva Pharmaceutical Substance Abuse Therapeutics Product Offered

11.9.3 Teva Pharmaceutical Substance Abuse Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.9.4 Teva Pharmaceutical Main Business Overview

11.9.5 Teva Pharmaceutical Latest Developments

12 Research Findings and Conclusion

List of Tables

Table 1. Substance Abuse Therapeutics Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of Opioid Addiction

Table 3. Major Players of Tobacco/Nicotine Addiction

Table 4. Major Players of Alcohol Dependence

Table 5. Substance Abuse Therapeutics Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 6. Global Substance Abuse Therapeutics Market Size by Type (2017-2022) & ($ Millions)

Table 7. Global Substance Abuse Therapeutics Market Size Market Share by Type (2017-2022)

Table 8. Substance Abuse Therapeutics Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 9. Global Substance Abuse Therapeutics Market Size by Application (2017-2022) & ($ Millions)

Table 10. Global Substance Abuse Therapeutics Market Size Market Share by Application (2017-2022)

Table 11. Global Substance Abuse Therapeutics Revenue by Players (2020-2022) & ($ Millions)

Table 12. Global Substance Abuse Therapeutics Revenue Market Share by Player (2020-2022)

Table 13. Substance Abuse Therapeutics Key Players Head office and Products Offered

Table 14. Substance Abuse Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 15. New Products and Potential Entrants

Table 16. Mergers & Acquisitions, Expansion

Table 17. Global Substance Abuse Therapeutics Market Size by Regions 2017-2022 & ($ Millions)

Table 18. Global Substance Abuse Therapeutics Market Size Market Share by Regions (2017-2022)

Table 19. Americas Substance Abuse Therapeutics Market Size by Country (2017-2022) & ($ Millions)

Table 20. Americas Substance Abuse Therapeutics Market Size Market Share by Country (2017-2022)

Table 21. Americas Substance Abuse Therapeutics Market Size by Type (2017-2022) & ($ Millions)

Table 22. Americas Substance Abuse Therapeutics Market Size Market Share by Type (2017-2022)

Table 23. Americas Substance Abuse Therapeutics Market Size by Application (2017-2022) & ($ Millions)

Table 24. Americas Substance Abuse Therapeutics Market Size Market Share by Application (2017-2022)

Table 25. APAC Substance Abuse Therapeutics Market Size by Region (2017-2022) & ($ Millions)

Table 26. APAC Substance Abuse Therapeutics Market Size Market Share by Region (2017-2022)

Table 27. APAC Substance Abuse Therapeutics Market Size by Type (2017-2022) & ($ Millions)

Table 28. APAC Substance Abuse Therapeutics Market Size Market Share by Type (2017-2022)

Table 29. APAC Substance Abuse Therapeutics Market Size by Application (2017-2022) & ($ Millions)

Table 30. APAC Substance Abuse Therapeutics Market Size Market Share by Application (2017-2022)

Table 31. Europe Substance Abuse Therapeutics Market Size by Country (2017-2022) & ($ Millions)

Table 32. Europe Substance Abuse Therapeutics Market Size Market Share by Country (2017-2022)

Table 33. Europe Substance Abuse Therapeutics Market Size by Type (2017-2022) & ($ Millions)

Table 34. Europe Substance Abuse Therapeutics Market Size Market Share by Type (2017-2022)

Table 35. Europe Substance Abuse Therapeutics Market Size by Application (2017-2022) & ($ Millions)

Table 36. Europe Substance Abuse Therapeutics Market Size Market Share by Application (2017-2022)

Table 37. Middle East & Africa Substance Abuse Therapeutics Market Size by Region (2017-2022) & ($ Millions)

Table 38. Middle East & Africa Substance Abuse Therapeutics Market Size Market Share by Region (2017-2022)

Table 39. Middle East & Africa Substance Abuse Therapeutics Market Size by Type (2017-2022) & ($ Millions)

Table 40. Middle East & Africa Substance Abuse Therapeutics Market Size Market Share by Type (2017-2022)

Table 41. Middle East & Africa Substance Abuse Therapeutics Market Size by Application (2017-2022) & ($ Millions)

Table 42. Middle East & Africa Substance Abuse Therapeutics Market Size Market Share by Application (2017-2022)

Table 43. Key Market Drivers & Growth Opportunities of Substance Abuse Therapeutics

Table 44. Key Market Challenges & Risks of Substance Abuse Therapeutics

Table 45. Key Industry Trends of Substance Abuse Therapeutics

Table 46. Global Substance Abuse Therapeutics Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 47. Global Substance Abuse Therapeutics Market Size Market Share Forecast by Regions (2023-2028)

Table 48. Global Substance Abuse Therapeutics Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 49. Global Substance Abuse Therapeutics Market Size Market Share Forecast by Type (2023-2028)

Table 50. Global Substance Abuse Therapeutics Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 51. Global Substance Abuse Therapeutics Market Size Market Share Forecast by Application (2023-2028)

Table 52. Indivior Details, Company Type, Substance Abuse Therapeutics Area Served and Its Competitors

Table 53. Indivior Substance Abuse Therapeutics Product Offered

Table 54. Indivior Substance Abuse Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 55. Indivior Main Business

Table 56. Indivior Latest Developments

Table 57. Pfizer Details, Company Type, Substance Abuse Therapeutics Area Served and Its Competitors

Table 58. Pfizer Substance Abuse Therapeutics Product Offered

Table 59. Pfizer Main Business

Table 60. Pfizer Substance Abuse Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 61. Pfizer Latest Developments

Table 62. Alkermes Details, Company Type, Substance Abuse Therapeutics Area Served and Its Competitors

Table 63. Alkermes Substance Abuse Therapeutics Product Offered

Table 64. Alkermes Main Business

Table 65. Alkermes Substance Abuse Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 66. Alkermes Latest Developments

Table 67. Novartis Details, Company Type, Substance Abuse Therapeutics Area Served and Its Competitors

Table 68. Novartis Substance Abuse Therapeutics Product Offered

Table 69. Novartis Main Business

Table 70. Novartis Substance Abuse Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 71. Novartis Latest Developments

Table 72. Mylan Details, Company Type, Substance Abuse Therapeutics Area Served and Its Competitors

Table 73. Mylan Substance Abuse Therapeutics Product Offered

Table 74. Mylan Main Business

Table 75. Mylan Substance Abuse Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 76. Mylan Latest Developments

Table 77. Cipla Details, Company Type, Substance Abuse Therapeutics Area Served and Its Competitors

Table 78. Cipla Substance Abuse Therapeutics Product Offered

Table 79. Cipla Main Business

Table 80. Cipla Substance Abuse Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 81. Cipla Latest Developments

Table 82. Glenmark Details, Company Type, Substance Abuse Therapeutics Area Served and Its Competitors

Table 83. Glenmark Substance Abuse Therapeutics Product Offered

Table 84. Glenmark Main Business

Table 85. Glenmark Substance Abuse Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 86. Glenmark Latest Developments

Table 87. Dr. Reddy's Laboratories Details, Company Type, Substance Abuse Therapeutics Area Served and Its Competitors

Table 88. Dr. Reddy's Laboratories Substance Abuse Therapeutics Product Offered

Table 89. Dr. Reddy's Laboratories Main Business

Table 90. Dr. Reddy's Laboratories Substance Abuse Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 91. Dr. Reddy's Laboratories Latest Developments

Table 92. Teva Pharmaceutical Details, Company Type, Substance Abuse Therapeutics Area Served and Its Competitors

Table 93. Teva Pharmaceutical Substance Abuse Therapeutics Product Offered

Table 94. Teva Pharmaceutical Main Business

Table 95. Teva Pharmaceutical Substance Abuse Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 96. Teva Pharmaceutical Latest Developments

List of Figures

Figure 1. Substance Abuse Therapeutics Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Substance Abuse Therapeutics Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global Substance Abuse Therapeutics Market Size Market Share by Type in 2021

Figure 7. Substance Abuse Therapeutics in Hospital & Clinics

Figure 8. Global Substance Abuse Therapeutics Market: Hospital & Clinics (2017-2022) & ($ Millions)

Figure 9. Substance Abuse Therapeutics in Residential (non-hospital)

Figure 10. Global Substance Abuse Therapeutics Market: Residential (non-hospital) (2017-2022) & ($ Millions)

Figure 11. Global Substance Abuse Therapeutics Market Size Market Share by Application in 2021

Figure 12. Global Substance Abuse Therapeutics Revenue Market Share by Player in 2021

Figure 13. Global Substance Abuse Therapeutics Market Size Market Share by Regions (2017-2022)

Figure 14. Americas Substance Abuse Therapeutics Market Size 2017-2022 ($ Millions)

Figure 15. APAC Substance Abuse Therapeutics Market Size 2017-2022 ($ Millions)

Figure 16. Europe Substance Abuse Therapeutics Market Size 2017-2022 ($ Millions)

Figure 17. Middle East & Africa Substance Abuse Therapeutics Market Size 2017-2022 ($ Millions)

Figure 18. Americas Substance Abuse Therapeutics Value Market Share by Country in 2021

Figure 19. Americas Substance Abuse Therapeutics Consumption Market Share by Type in 2021

Figure 20. Americas Substance Abuse Therapeutics Market Size Market Share by Application in 2021

Figure 21. United States Substance Abuse Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 22. Canada Substance Abuse Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 23. Mexico Substance Abuse Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 24. Brazil Substance Abuse Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 25. APAC Substance Abuse Therapeutics Market Size Market Share by Region in 2021

Figure 26. APAC Substance Abuse Therapeutics Market Size Market Share by Application in 2021

Figure 27. China Substance Abuse Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 28. Japan Substance Abuse Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 29. Korea Substance Abuse Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 30. Southeast Asia Substance Abuse Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 31. India Substance Abuse Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 32. Australia Substance Abuse Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 33. Europe Substance Abuse Therapeutics Market Size Market Share by Country in 2021

Figure 34. Europe Substance Abuse Therapeutics Market Size Market Share by Type in 2021

Figure 35. Europe Substance Abuse Therapeutics Market Size Market Share by Application in 2021

Figure 36. Germany Substance Abuse Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 37. France Substance Abuse Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 38. UK Substance Abuse Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 39. Italy Substance Abuse Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 40. Russia Substance Abuse Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 41. Middle East & Africa Substance Abuse Therapeutics Market Size Market Share by Region in 2021

Figure 42. Middle East & Africa Substance Abuse Therapeutics Market Size Market Share by Type in 2021

Figure 43. Middle East & Africa Substance Abuse Therapeutics Market Size Market Share by Application in 2021

Figure 44. Egypt Substance Abuse Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 45. South Africa Substance Abuse Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 46. Israel Substance Abuse Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 47. Turkey Substance Abuse Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 48. GCC Country Substance Abuse Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 49. Americas Substance Abuse Therapeutics Market Size 2023-2028 ($ Millions)

Figure 50. APAC Substance Abuse Therapeutics Market Size 2023-2028 ($ Millions)

Figure 51. Europe Substance Abuse Therapeutics Market Size 2023-2028 ($ Millions)

Figure 52. Middle East & Africa Substance Abuse Therapeutics Market Size 2023-2028 ($ Millions)

Figure 53. United States Substance Abuse Therapeutics Market Size 2023-2028 ($ Millions)

Figure 54. Canada Substance Abuse Therapeutics Market Size 2023-2028 ($ Millions)

Figure 55. Mexico Substance Abuse Therapeutics Market Size 2023-2028 ($ Millions)

Figure 56. Brazil Substance Abuse Therapeutics Market Size 2023-2028 ($ Millions)

Figure 57. China Substance Abuse Therapeutics Market Size 2023-2028 ($ Millions)

Figure 58. Japan Substance Abuse Therapeutics Market Size 2023-2028 ($ Millions)

Figure 59. Korea Substance Abuse Therapeutics Market Size 2023-2028 ($ Millions)

Figure 60. Southeast Asia Substance Abuse Therapeutics Market Size 2023-2028 ($ Millions)

Figure 61. India Substance Abuse Therapeutics Market Size 2023-2028 ($ Millions)

Figure 62. Australia Substance Abuse Therapeutics Market Size 2023-2028 ($ Millions)

Figure 63. Germany Substance Abuse Therapeutics Market Size 2023-2028 ($ Millions)

Figure 64. France Substance Abuse Therapeutics Market Size 2023-2028 ($ Millions)

Figure 65. UK Substance Abuse Therapeutics Market Size 2023-2028 ($ Millions)

Figure 66. Italy Substance Abuse Therapeutics Market Size 2023-2028 ($ Millions)

Figure 67. Russia Substance Abuse Therapeutics Market Size 2023-2028 ($ Millions)

Figure 68. Spain Substance Abuse Therapeutics Market Size 2023-2028 ($ Millions)

Figure 69. Egypt Substance Abuse Therapeutics Market Size 2023-2028 ($ Millions)

Figure 70. South Africa Substance Abuse Therapeutics Market Size 2023-2028 ($ Millions)

Figure 71. Israel Substance Abuse Therapeutics Market Size 2023-2028 ($ Millions)

Figure 72. Turkey Substance Abuse Therapeutics Market Size 2023-2028 ($ Millions)

Figure 73. GCC Countries Substance Abuse Therapeutics Market Size 2023-2028 ($ Millions)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390